Related Experiment Video
Updated: May 25, 2025
A Two-Step Method for Percutaneous Transhepatic Choledochoscopic Lithotomy
Published on: September 13, 2022
Unveiling the Genetic Culprit: A Diagnostic Dilemma of Recurrent Cholestasis With Intrahepatic Stones
Jacob A Ciricillo1, Farrah Rahim2, Yeshika Sharma1
1Division of Digestive Diseases, University of Cincinnati Medical Center, Cincinnati, OH.
Insights
Mutations in the ABCB4 gene cause recurrent cholestasis, a liver condition. Genetic testing and early treatment can prevent severe liver disease progression.
Area of Science:
- Hepatology
- Genetics
- Biochemistry
Background:
- Recurrent cholestasis presents diagnostic difficulties, requiring frequent medical interventions.
- The ABCB4 gene provides instructions for making a protein crucial for phospholipid transport in bile.
- ABCB4 protein dysfunction, due to mutations, results in various liver conditions characterized by cholestasis.
Observation:
- A case study of a young female experiencing recurrent cholestasis after gallbladder removal.
- The patient presented with intrahepatic stones and a history of intrahepatic cholestasis of pregnancy.
- Diagnostic challenges were noted due to the recurrent nature of the cholestasis.
Findings:
- ABCB4 gene mutations are linked to a spectrum of clinical syndromes causing recurrent cholestasis, itching, and jaundice.
- The patient's phenotype suggests a potential link to ABCB4-related liver disorders.
- Intrahepatic stones and recurrent cholestasis of pregnancy were key clinical features.
Implications:
- Consider ABCB4 mutations in unexplained cholestasis cases.
- Early genetic diagnosis of ABCB4 mutations is vital.
- Prompt treatment with ursodeoxycholic acid may halt disease advancement, preventing liver fibrosis and end-stage liver disease.
Abstract:
Recurrent cholestasis poses diagnostic challenges and necessitates repeated testing. The ABCB4 (adenosine triphosphate-binding cassette, subfamily B, member 4) gene encodes a protein that removes phospholipids from the hepatic canalicular membrane through bile salts. Mutations lead to a spectrum of clinical syndromes that cause recurrent cholestasis, pruritus, and jaundice. This case follows a young female with recurrent cholestasis postcholecystectomy, intrahepatic stones on endoscopic retrograde cholangiopancreatography, and repeated intrahepatic cholestasis of pregnancy. Phenotypes of ABCB4 mutations should be considered when facing cholestasis of unclear etiology. Early genetic testing and ursodeoxycholic acid treatment may prevent progression toward hepatic fibrosis and end-stage liver disease.
Related Concept Videos
01:24Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
01:26Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
01:29Chronic Pancreatitis II: Collaborative Care
Assessment:
01:17Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...